一氧化二氮冷冻治疗食管鳞状上皮内瘤变:新型便携式冷冻球囊消融系统的首次国际多中心体验(附视频)
本研究评估使用一氧化二氮冷冻球囊局灶消融系统(CbFAS)内镜根除早期食管鳞状上皮内瘤变的可行性。10例患者(24处碘不染病灶)接受治疗,中位随访10.7个月,全部患者达到完全内镜和组织学缓解,无严重不良事件,4例出现轻度自限性胸痛,2例环周消融后发生狭窄经扩张缓解。作者认为疗效高、安全性合理,需前瞻性试验优化冷冻剂量并评估安全性和疗效。
要点
- CbFAS可完成早期食管鳞状上皮内瘤变的消融,所有患者3个月时达完全内镜和组织学缓解。
- 无严重不良事件;4例术后即出现轻度自限性胸痛需麻醉性镇痛药,2例环周消融后狭窄经扩张缓解。
- 7例1年随访活检未见碘不染病灶或食管鳞状上皮内瘤变,末次随访全部无病生存。
核心结论
- 作者报告首次将一氧化二氮冷冻球囊消融用于早期原发或复发食管鳞状上皮内瘤变的治愈性治疗,初步经验显示疗效高且安全性合理,需前瞻性试验优化冷冻剂量并评估安全性和疗效。
研究设计与样本
- 本研究为首次国际多中心体验,评估便携式一氧化二氮冷冻球囊局灶消融系统(CbFAS)内镜根除早期食管鳞状上皮内瘤变的可行性。
- CbFAS由含液态一氧化二氮的手持装置组成,在低压力顺应性经内镜球囊内转化为气体,冷冻与球囊接触的靶黏膜。
- 纳入早期食管鳞状上皮内瘤变患者,定义为低级别上皮内瘤变(LGIN)、高级别上皮内瘤变(HGIN)或早期T1鳞状黏膜癌。
- 染色内镜后对所有卢戈氏碘不染病灶(USL)按每部位8、10或12秒冰敷治疗,重复治疗直至活检样本证实食管鳞状上皮内瘤变根除。
- 共10例患者(4例男性;中位年龄69.5岁)接受治疗,病灶为LGIN(n=2)、HGIN(n=7)或食管鳞状细胞癌(ESCC;n=1,EMR后),共24处USL。
主要发现
- 最大USL的中位最大直径为1.5 cm(四分位距1-2 cm),所有肿瘤性USL的中位总长度为2 cm(范围1-10 cm)。
- 局灶病变患者中位接受2次冷冻消融,而4例大和/或多灶环周瘤变患者每次操作接受6至12次消融。
- 中位操作时间为34分钟(范围18-57分钟),所有患者均完成治疗,无严重不良事件。
- 4例患者术后即刻出现轻度自限性胸痛需麻醉性镇痛药;2例接受环周消融的患者发生狭窄,经扩张缓解,无复发。
- 所有患者3个月时达到完全内镜和组织学缓解;7例患者1年随访活检未见USL或食管鳞状上皮内瘤变;末次随访全部无病生存,中位随访时间10.7个月(四分位距4-14个月)。
临床怎么用
- 作者认为CbFAS对早期原发或复发食管鳞状上皮内瘤变的治愈性治疗疗效高且安全性合理,但需前瞻性试验优化冷冻剂量并评估安全性和疗效。
局限性
- 作者指出需前瞻性试验来优化冷冻剂量并评估安全性和疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Early esophageal squamous cell neoplasia (ESCN) can be successfully treated by EMR, endoscopic submucosal dissection (ESD), or radiofrequency ablation. A new portable, battery-powered cryotherapy system using nitrous oxide (cryoballoon focal ablation system [CbFAS]) has been used for Barrett's esophagus. It consists of a small hand-held device containing liquid nitrous oxide, which converts to gas within a low-pressure-compliant through-the-scope balloon and freezes targeted mucosa in contact with the balloon. This study evaluated the feasibility of endoscopic eradication of early ESCN with the CbFAS. METHODS: Patients with early ESCN (defined as low-grade intraepithelial neoplasia [LGIN], high-grade intraepithelial neoplasia [HGIN], or early T1 squamous mucosal cancer) were treated with the CbFAS. After chromoendoscopy, all Lugol's unstained lesions (USLs) were targeted with 8, 10, or 12 seconds of ice per site, and treatment was repeated until biopsy samples demonstrated eradication of ESCN. Postprocedure adverse events were recorded. RESULTS: Ten patients (4 men; median age, 69.5 years) with LGIN (n=2), HGIN (n=7), or esophageal squamous cell carcinoma (ESCC; n=1, after EMR) in 24 USLs were treated. The median maximum diameter of the largest USL was 1.5 cm (interquartile range, 1-2 cm), and median total length of all neoplastic USLs was 2 cm (range, 1-10 cm). Patients with focal disease received a median of 2 cryoablations, whereas 4 patients with large and/or multifocal circumferential neoplasia had 6 to 12 ablations per procedure. The median procedure time was 34 minutes (range, 18-57 minutes). Treatment was completed in all patients. No major adverse events occurred. Four patients developed mild self-limited chest pain requiring narcotic analgesics immediately after the procedure. Two patients who received circumferential ablation developed a stricture responding to dilation, with no recurrence. Complete endoscopic and pathologic response was achieved in all patients at 3 months. One year follow-up biopsy specimens in 7 patients showed no USL or ESCN. All patients were disease free at last visit, with a median follow-up time of 10.7 months (interquartile range, 4-14 months). CONCLUSIONS: We report the first application of nitrous cryoballoon ablation for curative treatment of early primary or recurrent ESCN. Our initial experience suggests that efficacy is high and the safety profile is reasonable. Prospective trials are needed to optimize cryogen dosimetry and assess safety and efficacy.
引用
- Canto MI, Abrams JA, Künzli HT, et al. Nitrous oxide cryotherapy for treatment of esophageal squamous cell neoplasia: initial multicenter international experience with a novel portable cryoballoon ablation system (with video). Gastrointest Endosc. 2017. PMID: 28720474. doi:10.1016/j.gie.2017.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。